Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $10,683 | 2 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $10,683 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $10,683 | 2 | Eli Lilly and Company ($10,683) |
All Payment Transactions
2 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/11/2023 | Eli Lilly and Company | — | — | In-kind items and services | $8,162.52 | Research |
| Study: A PHASE I PARTICIPANT- AND INVESTIGATOR-BLIND SINGLE-CENTER STUDY TO INVESTIGATE THE SAFETY TOLERABILITY AND PHARMACOKINETICS OF MULTIPLE DOSES OF LY3871801 IN HEALTHY ASIAN AND NON-ASIAN PARTICIPANTS | ||||||
| 02/21/2023 | Eli Lilly and Company | — | — | In-kind items and services | $2,520.09 | Research |
| Study: A SINGLE-ASCENDING DOSE STUDY TO EVALUATE THE SAFETY TOLERABILITY PHARMACOKINETICS AND PHARMACODYNAMICS OF LY3875383 IN HEALTHY PARTICIPANTS AND PARTICIPANTS WITH HYPERTRIGLYCERIDEMIA | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE I PARTICIPANT- AND INVESTIGATOR-BLIND SINGLE-CENTER STUDY TO INVESTIGATE THE SAFETY TOLERABILITY AND PHARMACOKINETICS OF MULTIPLE DOSES OF LY3871801 IN HEALTHY ASIAN AND NON-ASIAN PARTICIPANTS | Eli Lilly and Company | $8,163 | 1 |
| A SINGLE-ASCENDING DOSE STUDY TO EVALUATE THE SAFETY TOLERABILITY PHARMACOKINETICS AND PHARMACODYNAMICS OF LY3875383 IN HEALTHY PARTICIPANTS AND PARTICIPANTS WITH HYPERTRIGLYCERIDEMIA | Eli Lilly and Company | $2,520 | 1 |
About Dr. Youngjun Kim, MD
Dr. Youngjun Kim, MD is a Clinical Pharmacology healthcare provider based in Cypress, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2017. The National Provider Identifier (NPI) number assigned to this provider is 1235661646.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Youngjun Kim, MD has received a total of $10,683 in payments from pharmaceutical and medical device companies, with $10,683 received in 2023. These payments were reported across 2 transactions from 1 company. The most common payment nature is "" ($10,683).
Practice Information
- Specialty Clinical Pharmacology
- Location Cypress, CA
- Active Since 04/03/2017
- Last Updated 05/31/2022
- Taxonomy Code 208U00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1235661646
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.